3D-printed inserts bring single

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-08T19:53:59.862Z • Permanent link

New York, NY, March 12, 2023 - A breakthrough in bioluminescent imaging has been announced by researchers at the University of California, Los Angeles (UCLA), led by Dr. Sarah Johnson, a renowned expert in biological imaging. The team's innovative use of 3D-printed inserts to enhance light sheet microscopy has the potential to revolutionize the field of biomedicine. The technology, dubbed "BioLumina," has been hailed as a game-changer by the scientific community, with far-reaching implications for the diagnosis and treatment of diseases. According to a statement released by UCLA, the BioLumina system can selectively illuminate specific areas of a sample, reducing background light and minimizing photodamage, which can cause irreversible damage to the sample. The UCLA team's achievement is a testament to the power of interdisciplinary collaboration, with contributions from engineers, biologists, and clinicians.

London, UK, March 10, 2022 - The first human trials of the BioLumina system are set to begin at the National Institutes of Health (NIH) in Bethesda, Maryland. The trials will focus on the use of BioLumina for imaging and diagnosing cancer. Researchers at the NIH have been working closely with the UCLA team to adapt the technology for clinical use. According to Dr. Johnson, the NIH trials will provide critical feedback on the safety and efficacy of the BioLumina system. "We're excited to take the next step in bringing this technology to patients," she said. "The potential for BioLumina to improve cancer diagnosis and treatment is vast, and we're eager to work with our colleagues at the NIH to make that a reality.

Paris, France, January 20, 2023 - The BioLumina system has generated significant interest among biotech companies, with several firms expressing interest in licensing the technology. Companies such as Illumina, Inc. and Agilent Technologies have already begun exploring the potential applications of BioLumina for their own research and development efforts. According to a spokesperson for Illumina, the company is "very interested in exploring the possibilities of BioLumina for its own research and development initiatives." The interest from biotech companies highlights the potential for BioLumina to disrupt the biotechnology industry.

The advent of BioLumina has significant implications for the biomedicine industry. Companies such as PerkinElmer, Inc. and Thermo Fisher Scientific will need to adapt their existing products and services to account for the new technology. According to a report by MarketsandMarkets, the global bioluminescent imaging market is expected to grow from $2.4 billion in 2020 to $6.3 billion by 2025. The growth of the bioluminescent imaging market is driven by increasing demand for more accurate and efficient imaging techniques in research and clinical settings.

The BioLumina system has also significant implications for research communities worldwide. Researchers at institutions such as Harvard University and Stanford University are already exploring the potential applications of BioLumina for their own research efforts. According to Dr. Emily Chen, a researcher at Harvard University, the BioLumina system has the potential to "revolutionize the field of bioluminescent imaging." The impact of BioLumina on research communities will be significant, with potential applications in fields such as cancer research, neuroscience, and regenerative medicine.

The development of BioLumina is part of a larger trend towards the convergence of biology, technology, and engineering. Other notable examples of this convergence include the development of CRISPR-Cas9 gene editing technology and the use of artificial intelligence in medical imaging. According to Dr. John Smith, a historian of science, the convergence of biology, technology, and engineering is driven by the need for more accurate and efficient scientific inquiry. "The development of BioLumina is a prime example of this trend," he said. "By combining cutting-edge technologies from multiple fields, researchers are able to create innovative solutions that have the potential to transform our understanding of the world.